Gong J - Search Results

1

Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.

Gong J, Wu D, Chuang J, Tuli R, Simard J, Hendifar A. Gong J, et al. Clin Ther. 2017 Nov;39(11):2135-2145. doi: 10.1016/j.clinthera.2017.09.015. Epub 2017 Oct 25. Clin Ther. 2017. PMID: 29079389 Review.

2

Meta-analyses of treatment standards for pancreatic cancer.

Gong J, Tuli R, Shinde A, Hendifar AE. Gong J, et al. Mol Clin Oncol. 2016 Mar;4(3):315-325. doi: 10.3892/mco.2015.716. Epub 2015 Dec 18. Mol Clin Oncol. 2016. PMID: 26998283 Free PMC article.

3

Targeting mTOR in Pancreatic Ductal Adenocarcinoma.

Iriana S, Ahmed S, Gong J, Annamalai AA, Tuli R, Hendifar AE. Iriana S, et al. Among authors: gong j. Front Oncol. 2016 Apr 25;6:99. doi: 10.3389/fonc.2016.00099. eCollection 2016. Front Oncol. 2016. PMID: 27200288 Free PMC article. Review.

4

Statins and pancreatic cancer.

Gong J, Sachdev E, Robbins LA, Lin E, Hendifar AE, Mita MM. Gong J, et al. Oncol Lett. 2017 Mar;13(3):1035-1040. doi: 10.3892/ol.2017.5572. Epub 2017 Jan 4. Oncol Lett. 2017. PMID: 28454210 Free PMC article.

5

A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed.

Gong J, Delioukina ML, Hendifar AE. Gong J, et al. World J Oncol. 2013 Oct;4(4-5):217-220. doi: 10.4021/wjon708w. Epub 2013 Sep 27. World J Oncol. 2013. PMID: 29147360 Free PMC article.

6

Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas.

Gong J, Yan J, Forscher C, Hendifar A. Gong J, et al. Drug Des Devel Ther. 2018 Apr 6;12:777-786. doi: 10.2147/DDDT.S140638. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29670334 Free PMC article. Review.

7

Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

Gong J, Le TQ, Massarelli E, Hendifar AE, Tuli R. Gong J, et al. J Immunother Cancer. 2018 Jun 4;6(1):46. doi: 10.1186/s40425-018-0361-7. J Immunother Cancer. 2018. PMID: 29866197 Free PMC article. Review.

8

Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification.

Chuang J, Gong J, Klempner SJ, Woo Y, Chao J. Chuang J, et al. Among authors: gong j. J Gastrointest Oncol. 2018 Jun;9(3):560-572. doi: 10.21037/jgo.2018.03.01. J Gastrointest Oncol. 2018. PMID: 29998022 Free PMC article. Review.

9

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.

Gong J, Hendifar A, Tuli R, Chuang J, Cho M, Chung V, Li D, Salgia R. Gong J, et al. Clin Transl Med. 2018 Oct 8;7(1):32. doi: 10.1186/s40169-018-0210-9. Clin Transl Med. 2018. PMID: 30294755 Free PMC article. Review.

10

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.

Gong J, Chehrazi-Raffle A, Placencio-Hickok V, Guan M, Hendifar A, Salgia R. Gong J, et al. Clin Transl Med. 2019 Mar 18;8(1):9. doi: 10.1186/s40169-019-0225-x. Clin Transl Med. 2019. PMID: 30887236 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,239 results

Search Page

Filters